Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2007, Vol. 109, No. 2, pp. 674-682.
Prepublished online as a Blood First Edition Paper on September 26, 2006; DOI 10.1182/blood-2006-06-030445.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Table
Right arrow All Versions of this Article:
blood-2006-06-030445v1
109/2/674    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cox, C. V
Right arrow Articles by Blair, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cox, C. V
Right arrow Articles by Blair, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 26, 2006
Accepted September 2, 2006

Characterisation of a progenitor cell population in childhood T cell Acute Lymphoblastic Leukaemia

Charlotte V Cox, Hannah M Martin, Pamela R Kearns, Paul Virgo, Roger S Evely, and Allison Blair*

Bristol Institute for Transfusion Sciences, University of Bristol, Bristol, UK
Dept of Cellular & Molecular Medicine, University of Bristol, Bristol, UK
Dept of Immunology, North Bristol NHS Trust, Bristol, UK
Bristol Haematology & Oncology Centre, Bristol, UK

* Corresponding author; email: allison.blair{at}nbs.nhs.uk.

A significant proportion of children with T-ALL continue to fail therapy, consequently characterisation of the cells that proliferate to maintain the disease should provide valuable information on the most relevant therapeutic targets. We have used in vitro suspension culture (SC) and nonobese diabetic/severe combined immune deficient (NOD/SCID) mouse assays to phenotypically characterise and purify T-ALL progenitor cells. Cells from 13 paediatric cases were maintained in vitro for at least 4 weeks and expanded in 8 cases. To characterise the progenitors, cells were sorted for expression of CD34 and CD4 or CD7 and the subfractions evaluated in vitro and in vivo. The majority of cells capable of long-term proliferation in vitro were derived from the CD34+/CD4- and CD34+/CD7- subfractions. Moreover, the CD34+/CD4- or CD7- cells were the only subfractions capable of NOD/SCID engraftment. These T-ALL cells successfully repopulated secondary and tertiary recipients with equivalent levels of engraftment, demonstrating self-renewal ability. The immunophenotype and genotype of the original leukaemia cells were preserved with serial passage in the NOD/SCIDs. These data demonstrate the long-term repopulating ability of the CD34+/CD4- and CD34+/CD7- subfractions in T-ALL and suggest that a cell with a more primitive phenotype was the target for leukaemic transformation in these cases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020